SimuGen Ltd

SimuGen is a gene profiling company applying techniques from computational biology and wet lab research to provide cheaper ethical healthcare. SimuGen creates value by bringing to market an analytically powerful solution to ascribe the toxicity of compounds, thereby extensively reducing downstream animal testing. This transcribes into vastly reduced costs and timelines in preclinical testing. Protection of our assets will be mediated through our proprietary databank of gene expression profiles and will be reinforced by future patents on our gene combinations and algorithms. As a platform technology our solution is easily transferable to a range of other markets, including personal care.

Quin Wills
Daniel Sheehan
Bernard Leong